|
Delayed
Nasdaq
01:30:00 07/04/2026 am IST
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 30/07 | Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection | CI |
| 30/06 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| Market Cap | 1.7TCr 1.46TCr 1.36TCr 1.25TCr 2.35TCr 1,62100Cr 2.36TCr 16TCr 6.31TCr 82TCr 6.37TCr 6.23TCr 2,70300Cr | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74TCr 1.49TCr 1.4TCr 1.28TCr 2.41TCr 1,66100Cr 2.42TCr 17TCr 6.47TCr 84TCr 6.53TCr 6.39TCr 2,77000Cr | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +1.04% | ||
| Current year | +2.04% |
| Current year | 74.49 | 76.07 | |
| 1 year | 63.19 | 76.07 | |
| 3 years | 51.9 | 84.67 | |
| 5 years | 51.9 | 87.88 | |
| 10 years | 26.49 | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 07/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 16/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 07/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/04/26 | Issuer sale | Director | 23,407 | 0.0105% | ||
| 27/02/26 | Tax | General Counsel | 185 | 0.0001% | ||
| 26/02/26 | Free | Director | 3,190 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.48% | -.--% | +14.08% | +0.80% | 1.7TCr | ||
| -0.44% | +0.34% | +29.00% | +15.50% | 23TCr | ||
| +0.24% | -0.10% | +5.21% | -17.52% | 15TCr | ||
| -0.72% | -1.69% | -21.86% | +22.12% | 13TCr | ||
| -2.86% | -4.94% | -55.67% | -12.75% | 6.98TCr | ||
| -0.75% | +0.38% | +11.46% | +18.60% | 5.23TCr | ||
| 0.00% | -1.38% | -16.80% | -14.19% | 5.09TCr | ||
| +1.24% | +0.09% | +31.80% | +30.45% | 4.38TCr | ||
| +1.78% | +4.13% | +43.03% | +49.72% | 4.07TCr | ||
| +0.37% | +3.83% | -15.88% | +46.52% | 3.4TCr | ||
| Average | -0.02% | +0.10% | +2.44% | +13.93% | 8.25TCr | |
| Weighted average by Cap. | -0.26% | -0.03% | +4.15% | +9.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 403.03Cr 345.96Cr 323.9Cr 296.59Cr 558.71Cr 38TCr 560.29Cr 3.84TCr 1.5TCr 19TCr 1.51TCr 1.48TCr 64TCr | 410.05Cr 351.99Cr 329.54Cr 301.75Cr 568.44Cr 39TCr 570.05Cr 3.9TCr 1.53TCr 20TCr 1.54TCr 1.51TCr 65TCr |
| Net income | 79Cr 68Cr 63Cr 58Cr 109.45Cr 7.54TCr 109.76Cr 751.32Cr 293.7Cr 3.8TCr 296.42Cr 290.01Cr 13TCr | 57Cr 49Cr 45Cr 42Cr 78Cr 5.4TCr 79Cr 538.34Cr 210.45Cr 2.72TCr 212.39Cr 207.8Cr 9.01TCr |
| Net Debt | 32Cr 28Cr 26Cr 24Cr 45Cr 3.07TCr 45Cr 305.76Cr 119.53Cr 1.55TCr 120.63Cr 118.03Cr 5.12TCr | 42Cr 36Cr 34Cr 31Cr 58Cr 4.02TCr 59Cr 400.54Cr 156.58Cr 2.03TCr 158.03Cr 154.61Cr 6.71TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
















